for market access
Market Access Strategy
At Valuate, we optimize value strategy and commercialization in the healthcare industry.
We combine deep expertise with advanced analytics to solve our clients’ market access challenges.
We help our clients optimize access across the product lifecycle. We consistently build successful strategies by:
Uniquely partnering with client teams
Listening carefully to the customer’s perspective
Deeply synthesizing inputs and client needs
Developing practical recommendations that work
Our goal is to turn Insights to Access™. Because we believe people deserve access to the healthcare they need.
Our market access optimization products get you the information you need to demonstrate value and measure success.
Examine. Customize. Optimize.
Integrated analysis to optimize communications and build customer equity.
Automated Pull-through Program
Optimize the value of acquired access through secondary analysis that targets, segments, and prioritizes physicians based on access dynamics.
Fill the gaps. Tell a story.
Assess, identify, and prioritize areas of focus for value evidence generation and strategy development
Rapid-response Payer Insights
A rapid-response survey platform tailored to market access decision makers
The story behind the story
Insights to unlock behavioral drivers for earlier detection of access opportunities and risks
We are former payers, PBM and provider executives, biopharma market access executives, pharmacists, data scientists, and business strategists working together to solve your market access challenges and demonstrate product value.
At Valuate, we do more than hand you a strategy document. We work by your side, collaborating to ensure plans are implemented and success is achieved.
Market access data scientist and analytics lead
JOHN HENNESSY, MBA
Health system, provider and oncology strategist with leadership positions at ASCO, ACCC, COA and USOncology
LORI WOOD, MHA
Commercial and behavioral health plan executive
TONY GIBSON, MHA
Health plan and hospital executive with experience in business planning and development
Market access strategist, client partner, and consultancy lead
We’ve got a clear point of view on how market access trends may affect brand performance.
Gross to Net Trends: What’s Ahead for Market Access?
Market Access POV:
ICER and Specialty
Pre-Approval Information Exchange Act pf 2022
Best Practices for Manufacturers
Subscribe to Valuate’s
Market Access Musings Newsletter
Listen to The IDI, a Podcast by and for Market Access Professionals
Reach Out to Us
We’re here to help with your market access strategy.
Valuate Health Consultancy: 225 Franklin Street, Boston, MA 02210